|
|
 Emtricitabine Information - July 20, 2008
| A new drug called therapy given to HIV-infected mothers can reduced the chances of the infant inheriting the deadly disease of AIDS by 40 percent, a new study reported Wednesday. Doctors say that a single dose of the drug nevirapine during labor is not only effective in prevention of mother-to-child HIV-1 transmission but also safe, cheap, and easy-to-use | | The Food and Drug Administration (FDA) has approved the sale of Atripla, a once-a-day pills that contains three FDA-approved drugs that can be taken in a single dose. The "cocktail" was approved for sale by the FDA on Wednesday and will be made available within seven working days. The new drug is expected to be a big help to HIV-positive patients | | A drug combination developed by a Silicon Valley company, Gilead Sciences, promise combating HIV in a small group of monkeys, The Associated Press reports. If larger tests show the drugs work, they could be given to people at highest risk of HIV - from gay men in American cities to women in Africa who catch the virus from their partners | | Scientists are hopeful that a cocktail of two drugs already used to treat HIV infection may prevent the spread of the virus. Thomas Folks, head of the HIV research lab at the U.S. Center for Disease Control and Prevention says, "This is the first thing I've seen that I think could have a prevention impact | |
|
|